Ken Griffin Biotricity Inc. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.46 - $0.79 $28 - $49
63 New
63 $0
Q3 2022

Nov 14, 2022
BUY
$0.78 - $1.75 $6,679 - $14,987
8,564 Added 56.43%
23,739 $19,000

Others Institutions Holding BTCY

# of Institutions
2
Shares Held
857
Call Options Held
0
Put Options Held
0
View Full List

About BIOTRICITY INC.

BTCY Quotes by TradingView
  • Ticker BTCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 50,431,200
  • Market Cap $20.7M
  • Description
  • Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile ...
More about BTCY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email